Yu Seong Lee

Abstract 2092: Artificial intelligence technology enables a rational development of a potent immunotherapeutic agent

Won Suk Lee, Jeong Hun Kim, Hye Jin Lee, 2020 .

Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer

Yu Seong Lee, W. Lee, Chan Kim, 2020, Journal for ImmunoTherapy of Cancer.

Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1

Yu Seong Lee, Joo‐Hang Kim, Chan Kim, 2020, Gene Therapy.

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

Yu Seong Lee, Jeong Hun Kim, J. Cheon, 2021, Journal for ImmunoTherapy of Cancer.

STING signaling is a potential immunotherapeutic target in colorectal cancer

Yu Seong Lee, Jung Hyun Noh, Seung Jun Lee, 2019, Journal of Cancer.

Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1

Yu Seong Lee, Joo‐Hang Kim, Chan Kim, 2020, Gene Therapy.

Abstract 1914: Orally available oncolytic reovirus, RC402, effectively promotes anti-cancer immunity and synergizes with immune checkpoint blockade in colon cancer

Yu Seong Lee, Jeong Hun Kim, Y. Lee, 2021, Immunology.

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect

Yu Seong Lee, C. Yun, J. Kim, 2006, Gene Therapy.